AI-Powered CRISPR-Cas9: Precision Therapeutics for ATP7B Mutations in Wilson Disease and Restoring Copper Metabolism

Authors

  • Husna Irfan Thalib , Aleesha Muzammil , Sarah Abdullah Alotaibi , Aya Sami Dahroug , Meral Alnuwaimi , Farrah Shams Author

DOI:

https://doi.org/10.48047/ms6yjk43

Keywords:

.

Abstract

Introduction: Wilson Disease is a genetic disorder caused by a mutation in ATP7B gene that leads to toxic copper accumulation in vital organs such as the liver, brain, kidneys, and eyes. The copper overload results in severe liver dysfunction, neurological problems, kidney impairment, and the hallmark feature called KayserFleischer rings in the eyes, which becomes progressively life-threatening if left untreated. With recent technological advancements, this research aims to explore the potential of using Artificial Intelligence (AI) with CRISPR-Cas9 gene-editing technology to develop precision therapies for correcting ATP7B mutations (28,29).

Downloads

Download data is not yet available.

References

Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNAguided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816-21. 2. Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096.

Downloads

Published

2025-02-20

How to Cite

AI-Powered CRISPR-Cas9: Precision Therapeutics for ATP7B Mutations in Wilson Disease and Restoring Copper Metabolism (Husna Irfan Thalib , Aleesha Muzammil , Sarah Abdullah Alotaibi , Aya Sami Dahroug , Meral Alnuwaimi , Farrah Shams , Trans.). (2025). Cuestiones De Fisioterapia, 54(4), 667-683. https://doi.org/10.48047/ms6yjk43